From the study description:
Primary Outcome Measures:1.
Incidence of adverse events[ Time Frame: Up to 30 days ]Toxicity will be graded according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 5.0. Observed toxicities/adverse events will be summarized in terms of type (organ affected or laboratory determination), severity, time of onset, duration, probable association with the study treatment and reversibility or outcome.
That's box 1 ticked!! Well done.
- Forums
- ASX - By Stock
- Ann: Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc
From the study description:Primary Outcome Measures:1.Incidence...
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
0.004(7.14%) |
Mkt cap ! $440.9M |
Open | High | Low | Value | Volume |
5.7¢ | 6.3¢ | 5.6¢ | $1.312M | 21.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 299223 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 450000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 296500 | 0.060 |
8 | 899945 | 0.059 |
10 | 1036582 | 0.058 |
11 | 2712529 | 0.057 |
13 | 718589 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 450000 | 3 |
0.062 | 615032 | 6 |
0.063 | 702930 | 9 |
0.064 | 564497 | 6 |
0.065 | 1433916 | 15 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online